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 Wastewater Analysis of Substance Use: 
Implications for Law, Policy and Research 
Jeremy Prichard, Foon Yin Lai, Emma van Dyken, Phong Thai, 
Raimondo Bruno, Wayne Hall, Paul Kirkbride, Coral Gartner, Jake 
O’Brien and Jochen F Mueller* 
This article seeks to encourage informed cross-disciplinary discourse about 
wastewater analysis (WWA) – a method of estimating substance use in very 
large populations through analysing samples of sewage water. The article 
examines Australia’s policy platform for responding to substance use, the 
National Drug Strategy (NDS). It then considers the evidence-base 
underpinning the NDS, particularly the metrics that are provided by national 
drug-monitoring systems. The article discusses the strengths of WWA and 
suggests the method could usefully augment existing monitoring systems. 
To demonstrate the flexibility, efficiency and scope of WWA, the article 
presents key findings from the first national WWA study, which 
encapsulated sewage samples from approximately 40% of the Australian 
population. Opportunities for WWA to inform time-sensitive issues in 
particular communities are also explored. The article encourages health and 
criminal justice portfolios to engage with WWA to ensure it is put to best 
effect for policy purposes.  
INTRODUCTION 
Substance use is relevant to multiple legislative frameworks, including health regulations and 
criminal laws – notably those that criminalise the production, distribution and consumption of certain 
drugs. Measuring substance use is, therefore, an important job in evaluating the effects of these 
frameworks. It is also inherently difficult, especially when consumption is clandestine as in the case 
of illicit drugs, black-market tobacco, or the extra-medical use of medicines. Australia has a well-
developed system for monitoring illicit substance use that draws on self-reports from substance users, 
hospital data on drug-related attendances, police arrest records and so on. This article analyses the 
potential implications of incorporating into the national monitoring system a new method for 
measuring trends in broad population consumption of illicit drugs. This approach is often called 
“wastewater analysis” (WWA).  
 Over the last decade WWA has moved beyond the proof-of-concept phase into an application 
phase. In other words, the science behind WWA has been accepted. For instance, the peak body that 
administers and co-ordinates drug monitoring at the population level in Europe has incorporated 
WWA into its ongoing monitoring framework.1 WWA is being used in all sorts of contexts – in 
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 Australia and elsewhere2 – as a new approach to measuring drug use that complements and enhances 
traditional methods. The standing of WWA has also grown in Australia. Indeed, in his 2015 address 
to the National Policing Summit, the CEO of the Australian Crime Commission described WWA as 
“the most effective and arguably the only objective means of reliably measuring the level of use of a 
number of prominent illicit drugs in catchment areas covered by the relevant wastewater facilities”.3  
 Despite WWA’s growing standing, very few publications have focused on its implications for 
policy or law.4 The vast majority of WWA publications to date have addressed scientific audiences.5 
The objective of this article is to promote discussion between disciplines about the implications of 
WWA for Australian law and policy in health and criminal justice.  
 The article is divided into four sections. It first describes Australia’s overarching policy platform 
on illicit drug use and the key drug monitoring systems in operation. Next, it explains how WWA 
works and how it is used in studying drug consumption trends. The article then uses the findings 
taken from a study by Lai et al 6  to demonstrate why a WWA monitoring system deserves 
consideration in Australia. This study analysed samples of wastewater taken from 14 municipal 
sewage treatment plants in six jurisdictions; collectively, these sewage treatment plants service 
approximately 40% of the Australian population. Finally, the article reflects on how WWA changes 
the role of chemistry in drug monitoring from a confirmatory tool to a primary exploratory tool. 
WWA invites researchers and policy-makers to think of new ways in which WWA can monitor trends 
in consumption of illicit drugs, tobacco and alcohol, in addition to human exposure to environmental 
pollutants.  
AUSTRALIA’S DRUG POLICY AND INFORMATION SOURCES 
The central objective of Australia’s National Drug Strategy (NDS) is to minimise harms to 
individuals, families and the wider community arising from the use of alcohol, tobacco and other 
substances, including illicit drugs.7 Estimates of the tangible costs of substance use to the Australian 
economy have included, among other things: losses in workforce labour; burdens placed on hospitals, 
nursing homes, ambulances and pharmaceutical subsidy schemes, as well as policing, court systems 
and prison systems; and property losses caused by crime.8 The tangible cost of tobacco consumption 
for the year 2004-2005 was estimated at $12 billion, alcohol consumption at $10.3 billion and illicit 
drugs at $6.9 billion.9  
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  The NDS is based on the three pillars of supply, demand and harm reduction strategies involving 
a wide variety of agencies. Supply reduction efforts are designed to prevent, stop, disrupt or otherwise 
reduce the production and supply of all illegal drugs, and to further control, manage and/or regulate 
the availability of legal drugs. This is achieved through the implementation of border protection and 
domestic policing methods, as well as the various laws directed towards both drug possession and 
trafficking.10 Demand reduction strategies aim to prevent the uptake of substance use by providing 
information and education. They are also aimed at discouraging initiation of substance use and 
encouraging and supporting current users to discontinue use. Demand reduction methods include 
public education campaigns, early intervention, drug treatment and rehabilitation programs, 
counselling and social integration. The objective of the harm reduction strategies is to reduce the 
adverse health, social and economic consequences of substance use on the individual, their family and 
the community. These strategies largely involve the diversion of offenders from the criminal justice 
system (and prison) into drug treatment and other health-related interventions, such as opioid 
maintenance treatment, supervised injecting rooms and needle and syringe programs that reduce drug-
related harm associated with continuing substance use.  
Monitoring Systems 
In addition to evidence provided by research centres and institutes, Commonwealth-funded agencies 
and other academic institutions, the NDS is informed by four key monitoring systems. The National 
Drug Strategy Household Survey (NDSHS) is conducted every three years, providing State, Territory 
and national-level data on substance use of around 25,000 Australians (aged 14 years and older).11 It 
is the country’s leading indicator of the prevalence of community use of alcohol, tobacco and illicit 
drugs and provides valuable data on the relative prevalence of the use of different substances as well 
as particular patterns of use, like binge drinking.12 Limitations of the NDSHS are that: it fails to 
capture those who live outside the traditional household context (eg prisoners, the homeless and 
hospitalised patients); 13  some sub-groups are too small for meaningful analysis; 14  and some 
respondents may be disinclined to report their substance use in a household survey.15  
 The Illicit Drug Reporting System (IDRS) has operated since 1999. It is currently conducted in 
all Australian jurisdictions annually. The primary source of information is a survey of people who 
inject drugs (N~1,000). Data are also collected via interviews of key informants who work in drug-
related fields.16 The IDRS also collects valuable data from health and law enforcement sectors. This 
includes police offence data, drug overdose data, and data on drug seizures from both the Australian 
Customs Service and the Australian NSP (Needle and Syringe Program) Survey.17 Information from 
these sectors complements and validates the interviews of key experts.  
 The Ecstasy and Related Drugs Reporting System (EDRS) complements the IDRS by targeting 
users of party-related drugs. The EDRS triangulates survey data from regular ecstasy users, 
interviews with professionals, and indirect sources relevant to the use of ecstasy and other party 
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 drugs.18 In 2015, 888 regular ecstasy users across Australia participated in the study.19 The IDRS and 
EDRS are specifically designed to quickly identify emergent trends in illicit drug markets through the 
examination of high-engagement groups that are poorly represented in prevalence studies but are 
likely the first to experience any market changes. The systems are not designed to provide drug-use 
information on all groups of substance users or to be population-representative.  
 The low prevalence of some types of illicit drug use means that the NDSHS has a limited 
capacity to identify trends in all illicit drugs, especially new substances20 such as “novel psychoactive 
substances”. However, the IDRS and EDRS work to counterbalance this issue because the methods 
employed by both systems have the sensitivity to produce data on a wide range of substances, 
including new ones. Typically data from IDRS and EDRS are available within 6-10 months after data 
collection. 
 Drug Use Monitoring Australia (DUMA), established in 1999, operates in six jurisdictions. Each 
year it asks arrestees in police detention to participate anonymously in a survey. In the 2013-2014 
period the sample size was 3,456 people.21 The typical response rate for the interview is 80%.22 In 
addition to completing the survey, participants are also asked to provide a urine sample and typically 
about 70% do so. Urine samples are analysed in a laboratory to detect use of cannabis, amphetamine-
type substances, cocaine and heroin.23 DUMA’s particular value lies in examining illicit drug use24 
among a cohort of people who are involved in the criminal justice system and hence are important for 
identifying patterns of substance use associated with criminal behaviour.25  
 All four monitoring systems use self-reported data as an essential source of information about 
individuals that helps to explain: how people use substances (eg route of administration, quantity of 
use, frequency of use and polydrug use); and the effects of substance use on their health, wellbeing 
and criminal behaviour. Self-report has some well-recognised limitations where illicit substance use is 
concerned.26 For instance, the stigma associated with illicit drug use – and even particular substances 
– may dissuade some individuals from disclosing their use.27 Other participants may unintentionally 
misreport what substances they have consumed because of memory lapses, or substance 
misidentification due to misleading and deceptive trade practices in the illicit drug market, among 
other things.28 
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 Other Mechanisms Informing Drug Policy in Australia  
There are other “indirect” data sources that provide information on the levels and types of drugs used 
in Australia as reflected in their adverse effects on the community as a whole – for example, the 
health of individual drug users and the association between drug use and crime. For instance, 
information on trends in ambulance attendances at opioid overdoses, drug overdose mortality, and 
drug-driving related deaths and injuries provide measures of the harms arising from substance use and 
decreases in these indicators suggest progress.29  
 Indirect data sources may be limited in the information they provide and can involve significant 
time lags between the date the data are collected and the date the results are released. By way of 
example, the most recent assessments of opioid-related deaths in Australia became available mid-
2016; these report final data for 2012 and estimates for 2014.30 Indirect data sources can also be 
difficult to interpret. For instance, data on the number and types of drug seizures and police arrests are 
often viewed as performance indicators for drug law enforcement agencies.31 Any increase in the 
number of drug seizures may indicate an increase in the amount of drugs circulating on the illicit 
market. It may, however, also reflect an increase in police resources directed to drug-related crime.32  
The Role of Chemistry in Monitoring Substance Use 
Chemical expertise informs the NDS in important ways. As noted above, the IDRS and EDRS 
regularly analyse the output of both medical and forensic laboratories. These laboratories use a wide 
array of sophisticated techniques to produce information on legal and illegal substances involved in 
drug-related deaths and traffic injuries and fatalities. They also verify the identity of substances seized 
in policing operations or border interdiction. DUMA employs a more direct analytical approach by 
submitting the collected urine samples from individual participants to analysis in a forensic 
laboratory.33  
 These chemical analyses often demand high levels of technical skill and experience in scientific 
investigation. However, in the case of metrics relevant to the NDS, the following points can be made 
about the role played by chemistry. First, the chemical metrics are not produced primarily to measure 
population substance use. While they do provide important metrics for the NDS, their primary 
purposes include medical treatment of patients, post-mortem evaluation of causes of death, and 
eventual contributions to evidence in criminal investigations. One exception is the DUMA urinalyses, 
which represent a systematic use of chemistry to monitor common types of substance use across a 
large, albeit non-representative, population. Yet, in DUMA as well as in the IDRS and the EDRS, it is 
clear that chemistry is supporting other disciplines – particularly epidemiology and criminology – to 
explore population-level substance consumption. Arguably the key role of chemistry in these studies 
is as a confirmatory tool. It confirms the identity and purity of substances seized by police services, 
confirms whether certain substances are present in arrestees’ urine or the blood of deceased people, 
and so on. As the following sections show, WWA introduces a new role for chemistry in illicit (and 
licit) drug monitoring. 
WASTEWATER ANALYSIS AND ITS USE IN DRUG MONITORING 
The analysis of wastewater for environmental contaminants has been undertaken for many decades 
but only relatively recently has it been used to examine traces of illicit drug use in the population. In 
2005, Zuccato’s team was the first to publish findings on traces of cocaine in Italian wastewater.34 
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 Since that time the amount of work undertaken by the scientific community has increased 
dramatically, with a heavy concentration of research in Europe, North America and Australia. An 
estimated 122 articles were published on WWA between 2008 and 2013.35  
 From a scientific perspective, the efficacy of the WWA method has been established. This means 
that the field has moved beyond “proof of concept” and into “application”. Among drug researchers, 
confidence in WWA is enhanced by the fact that the data it produces broadly match patterns observed 
using other more traditional research methods as to: (a) the prevalence at which different drugs are 
consumed; (b) changes in drug consumption over time; and (c) differences in drug consumption 
between geographical areas.36  
 As explained elsewhere,37 after an illicit drug is consumed (by whatever route) it leaves the 
bloodstream and is excreted in media such as sweat, saliva, faeces and urine. Depending on the drug, 
the chemicals that may be excreted include the unchanged (“parent”) drug and, for most drugs, their 
metabolites, which are produced by the interaction between the body’s enzymes and the parent 
compound. While individual capacity to metabolise drugs can vary greatly, in very large populations 
the average excretion profile is a reliable measure (because it is averaged across a very large number 
of users) and WWA has even been used to redefine excretion factors for some compounds.38 The 
method has been used to understand prison drug markets and may be superior to traditional means of 
monitoring drug consumption in prisons, such as random urine testing.39 WWA has also been used to 
monitor drug consumption at music festivals, schools and workplaces.40  
 Its use in law enforcement operations appears at this stage just to be theoretical.41 The main use 
of WWA to date has been to analyse illicit drug consumption in the general community, including to 
examine long-term trends over periods of years.42 In fact, Europe’s peak drug agency, the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA), has incorporated WWA into its 
annual monitoring systems – recently completing analyses of 41 cities with a combined catchment 
population of approximately 24 million people.43  EMCDDA has noted the value of WWA as a 
monitoring tool that can efficiently deliver data on dynamic illicit drug markets. In our experience, 
raw data can be provided to authorities about two months after sampling.  
How Does Wastewater Analysis Work?  
The value of WWA data depends on the way in which the samples are collected at sewage treatment 
plants. Fortunately, detailed standard sampling procedures have been formulated by Ort et al44 and the 
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 consistency of these procedures has enabled simultaneous comparisons of drug consumption across 
many European sampling sites. 45  In many WWA studies, sampling is continuous and flow 
proportional. This means that as wastewater flow increases, the sampling machine will also increase 
uptake in order to compensate. Conversely, sampling uptake will decrease as the total water flow 
decreases. The critical benefit of using this method is that each day WWA researchers can collect 
samples that are representative of all wastewater that has passed through the sampler in a 24-hour 
period.  
 In the laboratory, chemical analyses are used to quantify the levels of parent drugs and 
metabolites in samples of wastewater.46 A standard measurement is an estimate of the milligrams of 
parent drugs and metabolites. This weight – or “load” – can be converted into an estimate of the pure 
active ingredient of a drug that has been consumed on a per capita basis by all the individuals in the 
wastewater catchment area. It does not represent the weight of the powder or substance consumed 
because this may have been diluted with “cutting agents”, such as sugar.  
 Researchers have been careful not to overstate the capabilities or understate the limitations of 
WWA. WWA has been advocated as a valuable additional tool for drug monitoring, not as a 
replacement for existing survey methods. The key limitation of WWA is its inability to provide 
information on the drug use of individuals, for instance on what types of substances they use, their 
frequency of use, quantity of use, and the harms associated with that consumption. This means that 
WWA cannot on its own determine whether an increase in the load of an illicit drug in sewerage 
water is the result of more people using that drug or of heavier drug use by existing drug users.47 
Changes in drug purity can also complicate interpretation. It is feasible that fluctuations in purity 
could be misinterpreted as increases or decreases in levels of consumption within the community.48 
Another limitation is the difficulties associated with measuring heroin. Heroin’s major metabolite is 
morphine and in wastewater samples this is indistinguishable from excretions due to consumption of 
morphine and codeine from legitimate pharmaceutical sources. Heroin’s minor metabolite (6-
acetylmorphine) is detected in wastewater but its loadings are often extremely low due to its 
instability in water. Estimation of heroin consumption is therefore very difficult through WWA and 
can only be attempted after compensating mathematically for morphine use.  
 The relatively well-accepted advantages of WWA are that it efficiently provides accurate high-
level consumption data on very large populations.49 It is objective inasmuch as it does not depend on 
self-reports of illicit drug use and therefore circumvents problems like selection effects and substance 
misidentification due to misleading and deceptive practices in the illicit drug market.50 It is also 
minimally influenced by police practices and resources, which differentiates it from drug-related 
arrest and seizure metrics that can fluctuate because of changes in policing strategies.51 Finally, the 
list of substances that can potentially be identified using WWA is staggering. It includes all major 
drugs of concern including cocaine, MDMA, ketamine, methamphetamine and cannabis.52 WWA can 
also identify many pharmaceuticals,53 as well as alcohol54 and tobacco.55 Since WWA methods arose 
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 out of environmental toxicology, it can also be used to investigate the fate of pollutants in sewage. 
Novel psychoactive substances can be detected by WWA,56 but because the usage rate of these is 
quite low and metabolic profiles for these drugs often are not known the approach may not be as 
efficient or effective as forensic analyses of drugs seized by police. 
RESULTS OF A PILOT NATIONAL STUDY USING WASTEWATER ANALYSIS 
This section discusses the scope, speed and flexibility of WWA and the type of data that it produces. 
It presents key findings of the first national WWA study of drug consumption and compares the 
results with broad trends in the NDSHS. Details about the scientific methods used to collect, store, 
transport and analyse the samples are contained in Lai et al’s 2016 publication.57 Several points are 
worth noting. First, the methods used accord with international standards and protocols.58 Second, 
samples were collected by local water authorities over about one week. This occurred in 14 
wastewater treatment plants across six jurisdictions in mid-2015: the Australian Capital Territory; 
Queensland; New South Wales; Victoria, Western Australia; and the Northern Territory. Three of 
these sites were in regional areas and the remainder were in urban centres. Estimates of the numbers 
of people serviced within the boundaries of the sewage treatment plants were derived with the 
assistance of the Australian Bureau of Statistics. Collectively, the plants serviced approximately 40% 
of the Australian population.  
 Our focus here is on cocaine, methamphetamine and MDMA. The health implications of 
consumption of these substances are well documented. One form of methamphetamine, crystalline 
methamphetamine (“ice”), is of particular interest to legal frameworks underpinning health and law 
enforcement agencies. This is because of indications that supply and demand has increased,59 and 
links between consumption and mental illnesses,60 aggression,61 myocardial infarctions and strokes,62 
and criminal activity.63 WWA studies in Queensland have demonstrated that consumption of cocaine 
and MDMA peak over weekends; the effect is less pronounced for methamphetamine, which appears 
to be consumed at more consistent levels across the week.64 It is important to recognise that WWA 
cannot differentiate between consumption of ice and other forms of methamphetamine, nor can it 
differentiate between smoking or injection of these drugs. 
 The NDSHS asks participants – aged 14 years or older – if they have used these drugs in the 
12 months preceding completion of the survey. This is defined as “recent use”. In terms of national 
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 consumption trends, the latest data indicate approximate parity between prevalence of recent use of 
ecstasy (2.5%), cocaine (2.1%) and methamphetamine/amphetamine (2.1%). 65  The NDSHS also 
reports consumption trends at the State and Territory level. However, significance tests are not 
conducted on the differences between jurisdictions and official advice cautions readers about 
“concluding significant differences, even in cases where there are apparently large substantive 
differences”.66 Consequently, jurisdiction figures are not presented in this paper. 
 Figure 1, below, presents the results of the pilot WWA national study. The bars show the 
estimated average number of milligrams detected per day per 1,000 people at each site. The error bars 
represent 95% confidence intervals and indicate variation between the days of sampling. 
FIGURE 1 Mean drug consumption (mg/day/1,000 people) by location 
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 The strongest feature of the results is that methamphetamine consumption patterns across the 
country differed from both cocaine and MDMA in the period of sampling. Methamphetamine 
consumption was comparatively uniform across the country, with an average of 500 mg per 1,000 
people per day in most sites. The site with the highest average estimated consumption, Vic-B (1,160 
mg), was about 3.5 times that of the lowest – the Australian Capital Territory (340 mg). The error 
bars for methamphetamine indicate relatively little fluctuation between the individual days of 
sampling, including variance between working days and weekend.67  
 By contrast, the national consumption of cocaine and MDMA was lower and more varied 
nationally. With cocaine, only three sites recorded an average consumption of 500 mg per day per 
1,000 people, all in New South Wales. Cocaine consumption was concentrated in New South Wales 
sites and was much lower in Western Australia, regional areas of Queensland and the Northern 
Territory. In fact the average estimated consumption of NSW-B (510 mg) was over 11 times the 
estimated quantities for Qld-D, WA, NT-A and Qld-C (< 45 mg). As the error bars indicate, 
considerable variation was observed between the individual days of sampling in some sites, notably 
NSW-A and NSW-B. The raw data indicated that consumption peaked on the weekend.68  
 Regarding MDMA, the average estimated daily consumption per 1,000 people was less than 
251 mg in 10 of the 14 sites. In the other remaining four sites, three were located in New South 
Wales. Sizeable fluctuations were recorded between the individual days of sampling, with peaks in 
MDMA consumption occurring over the weekend. These patterns – sizeable weekend peaks for 
cocaine and MDMA, but not methamphetamine – are consistent with patterns observed in other 
Australian studies discussed earlier.69 The standard deviation for estimated consumption in NSW-B 
was extremely large. The estimated milligrams per 1,000 people ranged from 110 mg to 4,690 mg in 
the period of sampling. More than any other site, NSW-B underscores the main limitation of the study 
– namely, its short data collection period. Clearly, a longer schedule of sampling would provide 
greater confidence about average consumption rates for all sites, including NSW-B. 
 Notwithstanding the short period of sampling, there were some interesting differences between 
the WWA results and those from the NDSHS. Unlike the NDSHS findings, which indicate broad 
parity in the prevalence of use of the three substances, the WWA data indicated that more 
methamphetamine was consumed than either cocaine or ecstasy. In terms of inter-jurisdictional 
differences, the NDSHS is not currently designed to compare State and Territory patterns with 
confidence. By contrast, the WWA data were able to rank the sites nationally in terms of levels of 
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 consumption. Data from future WWA studies conducted over a longer period of time could be used to 
determine whether the differences observed between jurisdictions are statistically significant. 
 These relatively simple comparisons illustrate the capacity of WWA to complement the NDSHS 
and other monitoring systems. In this vein, arguably the most important conclusions to draw from 
Figure 1 relate to policy. Figure 1 demonstrates that with a good uniform WWA method, data can be 
collected and analysed from multiple sites across the country. Although sampling took place over a 
small period of time (which in a sense introduced a time-based selection effect), the study was not 
subject to the selection effects associated with surveys, such as missing certain types of substance 
users. The samples were collected with the assistance of water and sewerage authorities using 
Australia’s sewerage infrastructure as a data collection tool. Consequently, the data were collected at 
a low cost and with minimal imposition on others. For instance, private individuals were not asked to 
disclose their substance use or to provide urine specimens. Health and law enforcement agencies were 
not required to facilitate the research or provide access to data and so forth. Furthermore, the data 
were based on wastewater samples obtained from extremely large sample sizes – hundreds of 
thousands of people in most jurisdictions. If these wastewater analyses were conducted regularly, as 
they are in Europe, longitudinal time series could map trends in Australia’s consumption of illicit 
drugs over time and space. It is worth emphasising one final point. Figure 1 presented WWA results 
on methamphetamine, cocaine and ecstasy. However, as explained earlier in section 2.1, with the 
same approach metrics could be generated on all major drugs of concern, alcohol, tobacco and 
particular pharmaceuticals that may be diverted to the black market.  
CHEMISTRY, WASTEWATER ANALYSIS AND NEW PARADIGMS 
In section 1.3, above, it was argued that currently chemistry is used as a confirmatory tool that 
usefully supplements drug monitoring systems. As sections 2 and 3 of this article demonstrate, 
chemistry’s role is quite different in WWA. It is the central exploratory tool that produces the core 
metric – estimated milligrams of each drug consumed per 1,000 people per day. Chemistry’s central 
role in WWA presents challenges for research and policy portfolios in health and justice that are 
interested in drug consumption. This is primarily because the WWA method (of sampling and 
laboratory analysis) and the WWA metrics are unfamiliar and conceptually different to social science 
techniques. In our view, the future of WWA will depend on new collaborations between research 
disciplines and government agencies. In our experience the analytical chemists who drive WWA 
prefer to work with a wide range of experts to help them: (a) design research projects to best address 
policy-relevant issues; and (b) interpret their results. This means that those from health and justice 
portfolios should realise that their engagement with the science of WWA is critical to ensure that it is 
used to best effect for policy purposes.  
 WWA may mean that sections of local, State, Territory and federal governments may discover a 
new shared interest. As noted, WWA can produce data on substance consumption, human exposure to 
pollutants, and the fate of pollutants in the biosphere. Consequently, new collaborations may develop 
between agencies in health, law enforcement, water quality and environmental regulation. In addition, 
agencies or research groups that wish to explore the potential of WWA will need to collaborate with 
the government agencies and private corporations that maintain and operate sewerage infrastructure. 
The importance of these agencies goes well beyond the practicalities of collecting wastewater 
samples. They also have information that is fundamental to the design of WWA projects, including 
the location and size of sewerage treatment plants and their catchments. The size and characteristics 
of sewerage infrastructure may vary greatly between regions of Australia because of multiple factors, 
including topography, wastewater governance and historical decisions about system design. Large 
catchments that service hundreds of thousands of people have the obvious advantage of efficient data 
collection. However, smaller catchments may present different opportunities. 
 Tasmania serves as a useful example to demonstrate the latter point. In recent years serious 
concerns have been raised about the effect of ice on rural towns in mainland Australia and links with 
 outlaw motorcycle gangs.70  Similar concerns have been raised about regions of Tasmania, with 
attention focused on the north-west of the State and particularly the town of Smithton. The CEO of 
Rural Health Tasmania estimated that up to 10% of Smithton’s population were “addicted” to ice.71 
Brett Whiteley MP (Liberal Federal Member for Braddon) took the view that ice use in Smithton was 
no worse than in other parts of the country, and thought the attention paid to Smithton in the 
Australian Broadcasting Corporation’s Lateline and Four Corners was unwarranted. 72  Alcohol, 
Tobacco and Other Drugs CEO, Jann Smith, suggested that available data did not indicate that ice use 
had increased dramatically.73 The debate could not be easily resolved because of limitations of the 
available data sources. Smithton is not identifiable in the NDSHS and is not included in the IDRS or 
EDRS, and consequently self-reported information about ice use was not readily accessible. Other 
“indirect” sources of information about substance use (as described above in 1.3) could not determine 
whether the use of methamphetamine in Smithton or other areas of Tasmania was a “problem, a crisis 
or an epidemic”.74  
 Arguably, the Smithton methamphetamine question could have been substantially resolved with 
WWA sampling over a period of months. Such a study would be feasible in Tasmania because of the 
layout of its sewerage infrastructure. Tasmania has 78 discrete sewerage treatment plants that service 
most population centres. Sixty-two of these service catchments have an estimated population of less 
than 10,000 people, including Smithton. With a selection of sampling sites, WWA data could provide 
an objective means of comparing estimated consumption rates in Smithton and other Tasmanian 
towns. These figures in turn could be compared with similar WWA studies completed in other parts 
of Australia, such as urban and regional parts of south-east Queensland75 and South Australia.76 If the 
data had indicated that, for example, Smithton’s rate of methamphetamine consumption was 
inexplicably high, the information would have supported the epidemic thesis. The State government 
could have then taken appropriate responses to resource-integrated demand and harm-reduction 
strategies along with supply-reduction strategies led by law enforcement agencies. On the other hand, 
if the WWA data had not indicated that ice consumption was remarkable in Smithton (or elsewhere), 
community fears could have been assuaged relatively promptly along with media and political 
interest.  
 The points to draw from this example are threefold. First, water authorities are essential 
stakeholders in WWA research. Second, knowledge of sewerage infrastructure may uncover new 
opportunities in particular regions, including regional areas with small populations. Finally, WWA is 
flexible. While this paper has underscored the utility of WWA as a monitoring tool, it can also be 
used to assess relatively short-term trends in drug consumption in specific regions. 
CONCLUSION 
Laws and regulations governing illicit drugs in health and criminal justice settings form part of 
Australia’s NDS. The effectiveness of the strategy is monitored through a number of ongoing 
programs. These have different foci but collectively they provide information about drug 
consumption in the general community, among other things. A wide variety of sources are analysed 
by the current systems, including self-reported information from individuals. In addition, “indirect” 
sources of drug-related events are analysed, such as arrests, overdose mortality and so forth.  
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  Given the breadth of data sources that are already drawn upon to understand the complex national 
drug market, it is appropriate to consider the merits of adding WWA to the existing monitoring 
regime. It is true that this method does not produce individual-level data and it does not indicate 
whether increased consumption reflects the involvement of new users, changes in drug purity or 
simply that the same users are using more frequently. Yet WWA has proven to have considerable 
strength in: (a) increasing the frequency at which drug monitoring occurs; and (b) efficiently 
producing detailed metrics on drug consumption in the general population, including in regional areas 
that are not regularly studied by existing monitoring systems.  
 The data presented in this paper showed consumption in 14 sites around Australia in six 
jurisdictions, which effectively constitutes the first national study of its kind. The data were collected 
over a short time period, so the accuracy of the long-term findings awaits confirmation from future 
research. The study was nonetheless useful as a demonstration of the capability of WWA. Based on 
catchments servicing 40% of the Australian population, the findings suggested that methamphetamine 
was consumed more consistently and at higher levels than either cocaine or MDMA. Whereas 
NDSHS data do not readily support inter-jurisdictional comparisons, the WWA study was able to 
compare multiple sites. It indicated, among other things, that New South Wales has the highest 
consumption of cocaine and MDMA. 
 WWA requires new ways of thinking about drug metrics, primarily because it is driven by 
chemistry – a discipline that hitherto has played a secondary role in drug monitoring. The WWA 
method is novel to the social scientist not only because of the role of chemistry but because the data 
collection “apparatus” is the nation’s sewer network. However, we hope that health and justice 
portfolios will see the value in creating a WWA monitoring program that will enable the country to 
benefit from the investments made over many decades in sewerage infrastructure. Unpacking the 
potential that lies in this sewerage infrastructure will be critical for WWA to be effective in setting 
health and law enforcement policies at the State, Territory and federal level. As discussed in the 
Tasmanian example, sewerage infrastructure may provide great flexibility in targeting drug 
consumption in locations of interest. The Smithton example also demonstrates that WWA can be used 
either for ongoing monitoring or to address discrete, time-sensitive issues of concern to communities 
and government agencies. 
 
